Related Experiment Video
Updated: Mar 29, 2026
09:38
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
14.5K
Influence of Human Factors on Coagulation Management in Cardiac Surgery: A Retrospective Analysis
Cyril Bachmann1, Teresa Di Primio1, Maria Sophia Gauger1
1Department of Anaesthesiology, Zurich City Hospital (Triemli Site), Zurich, Switzerland.
Journal of Cardiothoracic and Vascular Anesthesia
|March 27, 2026
Summary
Anesthesiologist experience and on-call status did not influence coagulation product use in cardiac surgery. However, female anesthesiologists administered more products, though this finding was descriptive due to the small sample size.
Area of Science:
- Anesthesiology
- Transfusion Medicine
- Cardiac Surgery
Background:
- Coagulation product administration in cardiac surgery can vary.
- Factors influencing these decisions require investigation.
Purpose of the Study:
- To assess if anesthesiologist experience (cases/year), on-call status, or sex impacts coagulation product use during cardiac surgery.
Main Methods:
- Retrospective observational analysis at a single center.
- Included patients undergoing various cardiac surgeries.
- Examined data from 8 cardiac anesthesiologists.
Main Results:
- No significant difference in coagulation product transfusion rates based on anesthesiologist experience (≥52 vs. <52 cases/year).
- No difference in administration rates when anesthesiologists were on-call.
- The two female anesthesiologists exhibited the highest administration rates.
Conclusions:
- Anesthesiologist experience and on-call status are not associated with coagulation product administration in cardiac surgery.
- A descriptive observation noted higher administration rates among female anesthesiologists, requiring further study.
Related Concept Videos
01:09Coagulation
11.9K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
11.9K
01:06Coagulation
1.7K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.7K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
15.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
15.3K
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
424
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
424
01:29Venous Thrombosis III: Interprofessional Care
465
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
465